BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23720174)

  • 1. [Antibiotics in patients with fever and neutropenia].
    Kern WV
    Dtsch Med Wochenschr; 2013 Jun; 138(23):1217-20. PubMed ID: 23720174
    [No Abstract]   [Full Text] [Related]  

  • 2. [Management of febrile neutropenia].
    Rolfes N; Lümmen G
    Urologe A; 2011 Jul; 50(7):810-2. PubMed ID: 21559914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia].
    Karthaus M; Meran JG; Geissler RG; Böhme A; Jürgens H; Ganser A
    Wien Med Wochenschr; 1998; 148(18):427-32. PubMed ID: 9888179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the epidemiology of infections in patients with febrile neutropenia].
    Karthaus M; Carratala J
    Wien Med Wochenschr; 2001; 151(3-4):47-52. PubMed ID: 11789419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections in neutropenic cancer patients.
    Marchetti O; Calandra T
    Lancet; 2002 Mar; 359(9308):723-5. PubMed ID: 11888579
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylactic antimicrobial agents and the importance of fitness.
    Baden LR
    N Engl J Med; 2005 Sep; 353(10):1052-4. PubMed ID: 16148291
    [No Abstract]   [Full Text] [Related]  

  • 7. [The immunosuppressed patient with opportunistic infection. This is now the responsibility of the general practitioner].
    Roos M
    MMW Fortschr Med; 2005 Mar; 147(11):21. PubMed ID: 15803845
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antimicrobial therapy of febrile neutropenia--current developments].
    Karthaus M; Cornely OA; Südhoff T; Meran J
    Wien Med Wochenschr; 2001; 151(3-4):66-72. PubMed ID: 11789421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-agent, broad-spectrum fluoroquinolones for the outpatient treatment of low-risk febrile neutropenia.
    Cooper MR; Durand CR; Beaulac MT; Steinberg M
    Ann Pharmacother; 2011 Sep; 45(9):1094-102. PubMed ID: 21862714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone alone or in Combination with Teicoplanin in the Management of Febrile Episodes in Neutropenic Children and Adolescents with Cancer on an Outpatient Base.
    Preis S; Jürgens H; Friedland C; Oudekotte-David AA; Thomas L; Göbel U
    Klin Padiatr; 1993; 205(4):295-9. PubMed ID: 8377450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever.
    Jun HX; Zhixiang S; Chun W; Reksodiputro AH; Ranuhardy D; Tamura K; Matsumoto T; Lee DG; Purushotaman SV; Lim V; Ahmed A; Hussain Y; Chua M; Ong A; Liu CY; Hsueh PR; Lin SF; Liu YC; Suwangool P; Jootar S; Picazo JJ
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S128-32; discussion S133-40. PubMed ID: 16253480
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antibiotic therapy in leukopenia].
    Böhme A; Shah PM; Stille W; Hoelzer D
    Praxis (Bern 1994); 1998 Sep; 87(36):1120-5. PubMed ID: 9782739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with fluorated quinolones of febrile neutropenia in patients with hematologic malignancies.
    Nenova IS; Goranov SE; Mateva NG; Ananoshtev NH
    Folia Med (Plovdiv); 2003; 45(1):13-9. PubMed ID: 12943062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial therapy for fever of unknown origin in neutropenia. Standard recommendations of the Work Group of Infections in Hematology and Oncology of the German Association of Hematology and Oncology].
    Link H; Blumenstengel K; Böhme A; Cornely O; Kellner O; Nowrousian MR; Ostermann H; Schiel X; Wilhelm M
    Dtsch Med Wochenschr; 1999 Apr; 124 Suppl 1():S3-8. PubMed ID: 10410648
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment at home, a wonderful prospect].
    Letonturier P
    Presse Med; 2004 Apr; 33(7):459. PubMed ID: 15105767
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of bacterial infections in neutropenic and immunocompromised patients].
    Helbig W; Tauchnitz R
    Z Gesamte Inn Med; 1992 Sep; 47(9):417-21. PubMed ID: 1441670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.
    Bucaneve G; Micozzi A; Menichetti F; Martino P; Dionisi MS; Martinelli G; Allione B; D'Antonio D; Buelli M; Nosari AM; Cilloni D; Zuffa E; Cantaffa R; Specchia G; Amadori S; Fabbiano F; Deliliers GL; Lauria F; Foà R; Del Favero A;
    N Engl J Med; 2005 Sep; 353(10):977-87. PubMed ID: 16148283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of febrile neutropenia in an acute oncology service.
    Sammut SJ; Mazhar D
    QJM; 2012 Apr; 105(4):327-36. PubMed ID: 22080099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering Committee.
    Slavin MA; Lingaratnam S; Mileshkin L; Booth DL; Cain MJ; Ritchie DS; Wei A; Thursky KA;
    Intern Med J; 2011 Jan; 41(1b):102-9. PubMed ID: 21272174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk assessment in fever and neutropenia in children with cancer: What did we learn?
    te Poele EM; Tissing WJ; Kamps WA; de Bont ES
    Crit Rev Oncol Hematol; 2009 Oct; 72(1):45-55. PubMed ID: 19195908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.